| Transplant indications | 2023 | An analysis of the worldwide utilization of HSCT for AML |
| Transplant indications | 2022 | Hematopoietic Stem Cell Transplantation in Nepal: International Partnership, Implementation Steps, and Clinical Outcomes |
| Transplant indications | 2017 | Latin America: the next region for haematopoietic transplant progress |
| Transplant indications | 2017 | Low-cost matched sibling bone marrow transplant for standard-risk thalassemia in a limited-resource setting |
| Transplant indications | 2016 | Hematopoietic Stem-Cell Transplantation in the Resource-Limited Setting: Establishing the First Bone Marrow Transplantation Unit in Bangladesh |
| Transplant indications | 2023 | Hematopoietic Stem Cell Transplantation Activity in China 2020-2021 During the SARS-CoV-2 Pandemic: A Report From the Chinese Blood and Marrow Transplantation Registry Group |
| Transplant indications | 2016 | Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global survey |
| Transplant indications | 2022 | Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022 |
| Transplant indications | 2019 | Bone Marrow Transplantation in Patients With Acute Leukemia In Cuba: Results From the Last 30 Years and New Opportunities Through International Collaboration |
| Transplant indications | 2016 | Hematopoietic Stem-Cell Transplantation in the Resource-Limited Setting: Establishing the First Bone Marrow Transplantation Unit in Bangladesh |
| Transplant indications | 2018 | Importance of Nongovernmental Organizations for the Establishment of a Successful Hematopoietic Stem-Cell Transplantation Program in a Developing Country |
| Transplant indications | 2017 | The Start-Up of the first Hematopoietic Stem Cell Transplantation Center in the Iraqi Kurdistan: a Capacity-Building Cooperative Project by the Hiwa Cancer Hospital, Sulaymaniyah, and the Italian Agency for Development Cooperation: an Innovative Approach |
| Transplant indications | 2019 | Narrowing the gap for hematopoietic stem cell transplantation in the East-Mediterranean/African region: comparison with global HSCT indications and trends |
| Transplant indications | 2022 | One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donors |
| Transplant indications | 2015 | One million haemopoietic stem-cell transplants: a retrospective observational study |
| Transplant indications | 2013 | Quantitative and qualitative differences in use and trends of hematopoietic stem cell transplantation: a Global Observational Study |
| Transplant indications | 2023 | Report on hematopoietic cell transplantations performed in 2018/2019 focusing on the trends of selection of stem cell sources in the Asia-Pacific region: APBMTActivity Survey |
| Transplant indications | 2021 | The Chinese HCT survey: a non-manipulated haploidentical transplantation procedure makes a novel contribution to data sharing within the regional and global transplant registries and to worldwide knowledge |
| Transplant indications | 2020 | The Global State of Hematopoietic Cell Transplantation for Multiple Myeloma: An Analysis of the Worldwide Network of Blood and Marrow Transplantation (WBMT) Database and the Global Burden of Disease Study |
| Transplant indications | 2021 | The paradox of haematopoietic cell transplant in Latin America |
| Standards Accreditation | 2024 | World Marrow Donor Association (WMDA) international standards unrelated hematopoietic stem cell donor registries |
| Standards Accreditation | 2023 | A guide to the collection of T-cells by apheresis for ATMP manufacturing—recommendations of the GoCART coalition apheresis working group |
| Standards Accreditation | 2020 | Adverse event reporting for cellular therapy products: Current status and future directions |
| Standards Accreditation | 2020 | Correction: Worldwide Network for Blood and Marrow Transplantation (WBMT) perspective: the role of biosimilars in hematopoietic cell transplant: current opportunities and challenges in low- and lower-middle income countries |
| Standards Accreditation | 2023 | Endemic or regionally limited bacterial and viral infections in haematopoietic stem-cell transplantation recipients:a Worldwide Network for Blood and Marrow Transplantation (WBMT) Review |
| Standards Accreditation | 2023 | Endemic or regionally limited parasitic and fungal infections in haematopoietic stem-cell transplantation recipients: a Worldwide Network for Blood and Marrow Transplantation (WBMT) Review |
| Standards Accreditation | 2014 | Essential requirements for setting up a stem cell processing laboratory |
| Standards Accreditation | 2016 | Global use of peripheral blood vs bone marrow as source of stem cells for allogeneic transplantation in patients with bone marrow failure |
| Standards Accreditation | 2016 | Haploidentical Hematopoietic Stem Cell Transplantation: A Global Overview Comparing Asia, the European Union, and the United States |
| Standards Accreditation | 2015 | Training practices of cell processing laboratory staff: analysis of a survey by the Alliance for Harmonization of Cellular Therapy Accreditation |
| Standards Accreditation | 2020 | Worldwide Network for Blood and Marrow Transplantation (WBMT) perspective: the role of biosimilars in hematopoietic cell transplant: current opportunities and challenges in low- and lower-middle income countries |
| Standards Accreditation | 2019 | Worldwide Network for Blood and Marrow Transplantation Recommendations for Establishing a Hematopoietic Cell Transplantation Program, Part I: Minimum Requirements and Beyond |
| Standards Accreditation | 2020 | Worldwide Network for Blood and Marrow Transplantation (WBMT) recommendations for establishing a hematopoietic stem cell transplantation program in countries with limited resources (Part II): Clinical, technical and socio-economic considerations |
| Standards Accreditation | 2021 | Worldwide Network for Blood and Marrow Transplantation (WBMT) Recommendations Regarding Essential Medications Required To Establish An Early Stage Hematopoietic Cell Transplantation Program |
| Standards Accreditation | 2022 | Worldwide Network for Blood and Marrow Transplantation (WBMT) Special Article on Key Elements in Quality and Accreditation in Hematopoietic Stem Cell Transplantation and Cellular Therapy |
| Regulation | 2022 | The activities and regulatory landscape of cellular therapies including hematopoietic cell transplantation in the world |
| Access | 2024 | Non-cryopreserved autologous peripheral blood stem celltransplantation for multiple myeloma and lymphoma incountries with limited resources: practice considerations fromthe Worldwide Network for Blood and Marrow Transplantation |
| Access | 2024 | Access to CAR T-cell therapy: Focus on diversity, equity and inclusion |
| Access | 2023 | American Society of Transplantation and Cellular Therapy (ASTCT) International Affair Committee: Report of the Third Workshop on Global Perspective to Access to Transplantation at the 2022 Tandem Meeting |
| Access | 2019 | Bridging the gap using telemedicine: optimizing an existing autologous hematopoietic SCT unit into an allogeneic hematopoietic SCT unit in Paraguay with the help of the WBMT |
| Access | 2024 | Continuous and differential improvement in worldwide access to hematopoietic cell transplantation: activity has doubled in a decade with a notable increase in unrelated and non-identical related donors |
| Access | 2023 | Improved access to HCT with reduced racial disparities through integration with leukemia care and haploidentical donors |
| Access | 2022 | Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012 |
| Access | 2019 | Special report: Summary of the first meeting of African Blood and Marrow Transplantation (AfBMT) group, Casablanca, Morocco, April 19–21, 2018 held under the auspices of the Worldwide Network for Blood andMarrow Transplantation (WBMT) |
| Novel cell gene therapy | 2022 | Gene and cell therapies in China_booming landscape under dual-track regulation |
| Novel cell gene therapy | 2021 | Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA) |
| Novel cell gene therapy | 2023 | Paving the Road for Chimeric Antigen Receptor T Cells: American Society for Transplantation and Cellular Therapy 80/20 Task Force Consensus on Challenges and Solutions to Improving Efficiency of Clinical Center Certification and Maintenance of Operations for Commercially Approved Immune Effector Cell Therapies |
| Novel cell gene therapy | 2023 | The Cell and Gene Therapy Consortiums Perspective on Harmonizing Data Collection for Patient Enrollment Therapy Ordering and Scheduling and Cell Collection |
| Novel cell gene therapy | 2022 | The EBMT Immune Effector Cell Nursing Guidelines on CAR‑T Therapy: A Framework for Patient Care and Managing Common Toxicities |
| Novel cell gene therapy | 2023 | Updated Indications for Immune Effector Cell Therapy: 2023 Guidelines from the American Society for Transplantation and Cellular Therapy (ASTCT) |
| HCT in crisis | 2020 | Changes in Hematopoietic Cell Transplantation Practices in Response to COVID-19: A Survey from the Worldwide Network for Blood & Marrow Transplantation (WBMT) |
| HCT in crisis | 2024 | Radiation hazards of the Ukraine nuclear power plants: how can international blood and marrow stem cell transplant societies help? |
| HCT in crisis | 2020 | Real-World Issues and Potential Solutions in Hematopoietic Cell Transplantation during the COVID-19 Pandemic: Perspectives from the Worldwide Network for Blood and Marrow Transplantation (WBMT) and Centerfor International Blood and Marrow Transplant Research Health Services and International Studies Committee |
| Donation | 2013 | Allogeneic hematopoietic stem cell donation—standardized assessment of donor outcome data: A consensus statement from the Worldwide Network for Blood and Marrow Transplantation (WBMT) |
| Donation | 2016 | Determination of Eligibility in Related Pediatric Hematopoietic Cell Donors: Ethical and Clinical Considerations. Recommendations from a Working Group of the Worldwide Network for Blood and Marrow Transplantation (WBMT) Association |
| Donation | 2022 | Prioritising health equity alongside donation safety_Authors reply |
| Donation | 2023 | Protection of haematopoietic progenitor cell donors: an updated overview of the European landscape |
| Donation | 2015 | Suitability Criteria for Adult Related Donors: A Consensus Statement from the Worldwide Network for Blood and Marrow Transplantation Standing Committee on Donor Issues |
| Donation | 2022 | Suitability of haematopoietic cell donors: updated consensus recommendations from the WBMT standing committee on donor issues |
| Donation | 2019 | Worldwide Network for Blood & Marrow Transplantation (WBMT) special article, challenges facing emerging alternate donor registries |
